Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into Etiology Article Swipe
Stella Lilles
,
Klari Heidmets
,
Kaisa Teele Oja
,
Karit Reinson
,
Laura Roht
,
Sander Pajusalu
,
Monica H. Wojcik
,
Katrin Õunap
,
Inga Talvik
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.20944/preprints202510.2271.v1
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.20944/preprints202510.2271.v1
Background/Objectives: Drug-resistant epilepsy (DRE) is a significant health problem leading to cognitive impairment and reduced quality of life. This study aimed to in-vestigate the incidence and etiology of DRE in children in Estonia. Methods: A retrospective, population-based study of childhood DRE was conducted in Estonia from January 1, 2013, to December 31, 2017. All cases were identified through the only two pediatric neurology departments in the country, both located at tertiary care hospitals (Tartu University Hospital and Tallinn Children’s Hospital), ensuring complete nationwide coverage. Epidemiological, magnetic resonance imaging (MRI), and genetic data (chromosomal microarray, single-gene tests, gene panels, and exome/genome se-quencing) were collected. Results: The incidence rate of childhood epilepsy was 84.1 per 100,000. DRE developed in 10% of children with new-onset epilepsy, corresponding to an incidence rate of 8.5 per 100,000. Etiologically relevant MRI abnormalities were identified in 43% of patients with DRE, most commonly congenital brain malformations (19%). Pathogenic single-gene sequence variants were detected in 27% of patients who underwent genetic testing. Copy number variants were identified in 4% of tested patients, and chromosomal aberrations in 1%. Four patients carried novel candidate disease genes, although their pathogenicity remains uncertain. The most frequent etiology of DRE was structural (29%), followed by genetic (19%), with combined etiologies (13%) also contributing significantly. Conclusions: Our study is the first epidemiological study of DRE in children in Estonia and the Baltic region. The relatively low incidence observed may reflect the comprehensive national ascertainment and centralized management of pediatric epilepsy in tertiary care centers.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- preprint
- Landing Page
- https://doi.org/10.20944/preprints202510.2271.v1
- https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pub
- OA Status
- green
- OpenAlex ID
- https://openalex.org/W4415718470
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415718470Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.20944/preprints202510.2271.v1Digital Object Identifier
- Title
-
Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into EtiologyWork title
- Type
-
preprintOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-30Full publication date if available
- Authors
-
Stella Lilles, Klari Heidmets, Kaisa Teele Oja, Karit Reinson, Laura Roht, Sander Pajusalu, Monica H. Wojcik, Katrin Õunap, Inga TalvikList of authors in order
- Landing page
-
https://doi.org/10.20944/preprints202510.2271.v1Publisher landing page
- PDF URL
-
https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pubDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pubDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4415718470 |
|---|---|
| doi | https://doi.org/10.20944/preprints202510.2271.v1 |
| ids.doi | https://doi.org/10.20944/preprints202510.2271.v1 |
| ids.openalex | https://openalex.org/W4415718470 |
| fwci | |
| type | preprint |
| title | Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into Etiology |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | |
| locations[0].id | doi:10.20944/preprints202510.2271.v1 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S6309402219 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Preprints.org |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pub |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.20944/preprints202510.2271.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5047458118 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Stella Lilles |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Stella Lilles |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5120196109 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Klari Heidmets |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Klari Heidmets |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5066287747 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7084-0238 |
| authorships[2].author.display_name | Kaisa Teele Oja |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kaisa Teele Oja |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5012357212 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8235-2138 |
| authorships[3].author.display_name | Karit Reinson |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Karit Reinson |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5074156234 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5727-6759 |
| authorships[4].author.display_name | Laura Roht |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Laura Roht |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5003781412 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5435-0781 |
| authorships[5].author.display_name | Sander Pajusalu |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Sander Pajusalu |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5000401192 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-8162-5031 |
| authorships[6].author.display_name | Monica H. Wojcik |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Monica H Wojcik |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5021203354 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4594-6364 |
| authorships[7].author.display_name | Katrin Õunap |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Katrin Õunap |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5075559839 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Inga Talvik |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Inga Talvik |
| authorships[8].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pub |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-31T00:00:00 |
| display_name | Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into Etiology |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.20944/preprints202510.2271.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S6309402219 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Preprints.org |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pub |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.20944/preprints202510.2271.v1 |
| primary_location.id | doi:10.20944/preprints202510.2271.v1 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S6309402219 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Preprints.org |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.preprints.org/frontend/manuscript/a32d2b9b88584a848145ab8167f473c7/download_pub |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.20944/preprints202510.2271.v1 |
| publication_date | 2025-10-30 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 34 |
| abstract_inverted_index.a | 5 |
| abstract_inverted_index.1, | 47 |
| abstract_inverted_index.4% | 170 |
| abstract_inverted_index.an | 125 |
| abstract_inverted_index.at | 69 |
| abstract_inverted_index.by | 201 |
| abstract_inverted_index.in | 29, 31, 43, 64, 116, 138, 156, 169, 177, 221, 223, 246 |
| abstract_inverted_index.is | 4, 214 |
| abstract_inverted_index.of | 16, 27, 38, 107, 118, 128, 140, 158, 171, 195, 219, 243 |
| abstract_inverted_index.to | 10, 21, 49, 124 |
| abstract_inverted_index.1%. | 178 |
| abstract_inverted_index.10% | 117 |
| abstract_inverted_index.27% | 157 |
| abstract_inverted_index.31, | 51 |
| abstract_inverted_index.43% | 139 |
| abstract_inverted_index.8.5 | 129 |
| abstract_inverted_index.All | 53 |
| abstract_inverted_index.DRE | 28, 40, 114, 196, 220 |
| abstract_inverted_index.MRI | 134 |
| abstract_inverted_index.Our | 212 |
| abstract_inverted_index.The | 104, 191, 229 |
| abstract_inverted_index.and | 13, 25, 76, 89, 98, 174, 225, 240 |
| abstract_inverted_index.low | 231 |
| abstract_inverted_index.may | 234 |
| abstract_inverted_index.per | 112, 130 |
| abstract_inverted_index.the | 23, 58, 65, 215, 226, 236 |
| abstract_inverted_index.two | 60 |
| abstract_inverted_index.was | 41, 110, 197 |
| abstract_inverted_index.who | 160 |
| abstract_inverted_index.84.1 | 111 |
| abstract_inverted_index.Copy | 164 |
| abstract_inverted_index.DRE, | 143 |
| abstract_inverted_index.Four | 179 |
| abstract_inverted_index.This | 18 |
| abstract_inverted_index.also | 208 |
| abstract_inverted_index.both | 67 |
| abstract_inverted_index.care | 71, 248 |
| abstract_inverted_index.data | 91 |
| abstract_inverted_index.from | 45 |
| abstract_inverted_index.gene | 96 |
| abstract_inverted_index.most | 144, 192 |
| abstract_inverted_index.only | 59 |
| abstract_inverted_index.rate | 106, 127 |
| abstract_inverted_index.were | 55, 101, 136, 154, 167 |
| abstract_inverted_index.with | 120, 142, 204 |
| abstract_inverted_index.(13%) | 207 |
| abstract_inverted_index.(DRE) | 3 |
| abstract_inverted_index.2013, | 48 |
| abstract_inverted_index.2017. | 52 |
| abstract_inverted_index.aimed | 20 |
| abstract_inverted_index.brain | 147 |
| abstract_inverted_index.cases | 54 |
| abstract_inverted_index.first | 216 |
| abstract_inverted_index.life. | 17 |
| abstract_inverted_index.novel | 182 |
| abstract_inverted_index.study | 19, 37, 213, 218 |
| abstract_inverted_index.their | 187 |
| abstract_inverted_index.(19%), | 203 |
| abstract_inverted_index.(19%). | 149 |
| abstract_inverted_index.(29%), | 199 |
| abstract_inverted_index.(MRI), | 88 |
| abstract_inverted_index.(Tartu | 73 |
| abstract_inverted_index.Baltic | 227 |
| abstract_inverted_index.genes, | 185 |
| abstract_inverted_index.health | 7 |
| abstract_inverted_index.number | 165 |
| abstract_inverted_index.tested | 172 |
| abstract_inverted_index.tests, | 95 |
| abstract_inverted_index.Estonia | 44, 224 |
| abstract_inverted_index.January | 46 |
| abstract_inverted_index.Tallinn | 77 |
| abstract_inverted_index.carried | 181 |
| abstract_inverted_index.disease | 184 |
| abstract_inverted_index.genetic | 90, 162, 202 |
| abstract_inverted_index.imaging | 87 |
| abstract_inverted_index.leading | 9 |
| abstract_inverted_index.located | 68 |
| abstract_inverted_index.panels, | 97 |
| abstract_inverted_index.problem | 8 |
| abstract_inverted_index.quality | 15 |
| abstract_inverted_index.reduced | 14 |
| abstract_inverted_index.reflect | 235 |
| abstract_inverted_index.region. | 228 |
| abstract_inverted_index.remains | 189 |
| abstract_inverted_index.through | 57 |
| abstract_inverted_index.100,000. | 113, 131 |
| abstract_inverted_index.December | 50 |
| abstract_inverted_index.Estonia. | 32 |
| abstract_inverted_index.Hospital | 75 |
| abstract_inverted_index.Methods: | 33 |
| abstract_inverted_index.Results: | 103 |
| abstract_inverted_index.although | 186 |
| abstract_inverted_index.centers. | 249 |
| abstract_inverted_index.children | 30, 119, 222 |
| abstract_inverted_index.combined | 205 |
| abstract_inverted_index.commonly | 145 |
| abstract_inverted_index.complete | 81 |
| abstract_inverted_index.country, | 66 |
| abstract_inverted_index.detected | 155 |
| abstract_inverted_index.ensuring | 80 |
| abstract_inverted_index.epilepsy | 2, 109, 245 |
| abstract_inverted_index.etiology | 26, 194 |
| abstract_inverted_index.followed | 200 |
| abstract_inverted_index.frequent | 193 |
| abstract_inverted_index.magnetic | 85 |
| abstract_inverted_index.national | 238 |
| abstract_inverted_index.observed | 233 |
| abstract_inverted_index.patients | 141, 159, 180 |
| abstract_inverted_index.relevant | 133 |
| abstract_inverted_index.sequence | 152 |
| abstract_inverted_index.tertiary | 70, 247 |
| abstract_inverted_index.testing. | 163 |
| abstract_inverted_index.variants | 153, 166 |
| abstract_inverted_index.candidate | 183 |
| abstract_inverted_index.childhood | 39, 108 |
| abstract_inverted_index.cognitive | 11 |
| abstract_inverted_index.conducted | 42 |
| abstract_inverted_index.coverage. | 83 |
| abstract_inverted_index.developed | 115 |
| abstract_inverted_index.epilepsy, | 122 |
| abstract_inverted_index.hospitals | 72 |
| abstract_inverted_index.incidence | 24, 105, 126, 232 |
| abstract_inverted_index.neurology | 62 |
| abstract_inverted_index.new-onset | 121 |
| abstract_inverted_index.patients, | 173 |
| abstract_inverted_index.pediatric | 61, 244 |
| abstract_inverted_index.resonance | 86 |
| abstract_inverted_index.underwent | 161 |
| abstract_inverted_index.Hospital), | 79 |
| abstract_inverted_index.Pathogenic | 150 |
| abstract_inverted_index.University | 74 |
| abstract_inverted_index.collected. | 102 |
| abstract_inverted_index.congenital | 146 |
| abstract_inverted_index.etiologies | 206 |
| abstract_inverted_index.identified | 56, 137, 168 |
| abstract_inverted_index.impairment | 12 |
| abstract_inverted_index.management | 242 |
| abstract_inverted_index.nationwide | 82 |
| abstract_inverted_index.relatively | 230 |
| abstract_inverted_index.structural | 198 |
| abstract_inverted_index.uncertain. | 190 |
| abstract_inverted_index.aberrations | 176 |
| abstract_inverted_index.centralized | 241 |
| abstract_inverted_index.chromosomal | 175 |
| abstract_inverted_index.departments | 63 |
| abstract_inverted_index.microarray, | 93 |
| abstract_inverted_index.significant | 6 |
| abstract_inverted_index.single-gene | 94, 151 |
| abstract_inverted_index.(chromosomal | 92 |
| abstract_inverted_index.Children’s | 78 |
| abstract_inverted_index.Conclusions: | 211 |
| abstract_inverted_index.contributing | 209 |
| abstract_inverted_index.exome/genome | 99 |
| abstract_inverted_index.in-vestigate | 22 |
| abstract_inverted_index.se-quencing) | 100 |
| abstract_inverted_index.Etiologically | 132 |
| abstract_inverted_index.abnormalities | 135 |
| abstract_inverted_index.ascertainment | 239 |
| abstract_inverted_index.comprehensive | 237 |
| abstract_inverted_index.corresponding | 123 |
| abstract_inverted_index.malformations | 148 |
| abstract_inverted_index.pathogenicity | 188 |
| abstract_inverted_index.Drug-resistant | 1 |
| abstract_inverted_index.retrospective, | 35 |
| abstract_inverted_index.significantly. | 210 |
| abstract_inverted_index.epidemiological | 217 |
| abstract_inverted_index.Epidemiological, | 84 |
| abstract_inverted_index.population-based | 36 |
| abstract_inverted_index.Background/Objectives: | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile |